Conventional treatment of hyperkalemia is restricted by adverse events, as well as a dearth of evidence supporting clinical use. Recent research has led to the development of two novel potassium binders with good safety profiles that allow patients to maintain or increase the use of RAASIs for cardio- and reno-protection.
A survey issued by the American Academy of Allergy Asthma and Immunology and Immune Deficiency Foundation found that only 4% of primary care practitioners were aware that guidelines existed for the diagnosis and management of primary immunodeficiency.
Upon completion of this activity, participants should be better able to: implement a multidisciplinary approach to the care of patients with psoriasis in order to effectively manage the underlying disease and associated comorbidities, assess recent findings in the medical literature regarding FDA-approved therapies for psoriasis, along with safety and efficacy data on novel therapies undergoing late-stage clinical trials, and illustrate the importance of patient-centered care on addressing burdens associated with psoriasis.
This CME activity reviews how to assess the type, stage, and functional classification of heart failure in hospitalized patients and how to develop a patient-centered, guideline-directed, evidence-based management plan for patients hospitalized with heart failure with reduced ejection fraction (HFrEF)
Duchenne Muscular Dystrophy – An Expanding Lifespan
This two session activity summarizes the differential diagnosis of DMD and applicable diagnostic approaches as well as assess the therapeutic potential of available and emerging treatment options for the management of DMD